Loading provider…
Loading provider…
Allergy & Immunology Physician in San Jose, CA
NPI: 1063528321Primary Practice Location
Allergy and Asthma Associates of Northern California a Medical Corp
4050 Moorpark Ave, San Jose, CA
Primary Employer
Baychildren's Physicians
primary-pediatrics.ubcp.org
HQ Phone
Get MD Alan's Phone NumberMobile
Get MD Alan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1979 - 2026

American Board of Allergy and Immunology
Allergy & Immunology

American Board of Pediatrics
Pediatrics
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Allergy and Immunology
1982 - 1984
San Francisco General Hospital, San Francisco
1980 - 1981
UCSF School of Medicine
medschool.ucsf.edu
Residency • Pediatrics
1978 - 1980
UTMB Health
utmb.edu
Medical School
Until 1977
San Francisco VA Medical Center
Internship • rotating internship
1977 - 1978
University of Texas
BA • honors
1969 - 1973
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 164 | 226 |
| 2 | 95012Measurement of inhaled nitric oxide gas | 155 | 211 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 131 | 156 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 83 | 100 |
| 5 | 95117Injection of incremental dosages of allergen, 2 or more injections | 50 | 588 |
Once versus twice daily dosing of terfenadine in the treatment of seasonal allergic rhinitis: US and European studies.
Authors: Chu, T. J., Yamate, M., Biedermann, A. A., Wolfe, J. D., Goldsobel, A. B.
Authors: Richard Deshazo, Amal Assa'Ad
Journal: Immunol Allergy Clin North Am
Publication Date: 2025-03-11
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: GSK3511294 (Depemokimab)
Lead Sponsor: COUR Pharmaceutical Development Company, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: CNP-201
Lead Sponsor: Wake Forest University Health Sciences
Collaborators: Northwestern University, Duke University
Intervention / Treatment: BEHAVIORAL: Treatment as Usual, BEHAVIORAL: PainCOACH Pain Coping Skills Training